Dexcom Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Dexcom Inc Unternehmen

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Dexcom Inc Informationen



BörsenkürzelDXCM

Name des UnternehmensDexcom Inc

IPO-datumApr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Anzahl der mitarbeiter10300

WertpapierartOrdinary Share

GeschäftsjahresendeApr 14

Addresse6340 Sequence Drive

StadtSAN DIEGO

BörseNASDAQ OMX - NASDAQ BASIC

LandUnited States of America

Postleitzahl92121

Telefon18582000200

Websitehttps://www.dexcom.com/

BörsenkürzelDXCM

IPO-datumApr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Führungskräfte von Dexcom Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

299.71K

+5252.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

39.80K

+4471.00%

Ms. Bridgette P. Heller

Independent Director

27.03K

-1012.00%

Mr. Kyle Malady

Independent Director

22.67K

-667.00%

Ms. Rimma Driscoll

Independent Director

9.04K

+5074.00%

Ms. Renee D. Gala

Independent Director

6.88K

+1161.00%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

299.71K

+5252.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

39.80K

+4471.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

Nach RegionUSD

Name

Umsatz

Anteil

United States

851.90M

70.45%

Outside of United states

357.40M

29.55%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

Aktionärsstatistik

Aktualisiert: Sat, Jan 24

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

12.54%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

3.99%

Geode Capital Management, L.L.C.

2.81%

Andere

70.11%

Aktionäre

Anteil

The Vanguard Group, Inc.

12.54%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

3.99%

Geode Capital Management, L.L.C.

2.81%

Andere

70.11%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

53.15%

Investment Advisor/Hedge Fund

26.54%

Hedge Fund

7.32%

Research Firm

4.05%

Pension Fund

2.18%

Bank and Trust

1.82%

Sovereign Wealth Fund

1.61%

Venture Capital

0.48%

Individual Investor

0.38%

Andere

2.48%

Institutionelle Beteiligung



Aktualisiert: Mon, Dec 8

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

2120

388.08M

103.93%

+205.32K

2025Q3

2198

388.02M

104.56%

+4.65M

2025Q2

2236

383.14M

106.39%

+1.38M

2025Q1

2227

382.03M

104.52%

-27.81M

2024Q4

2209

376.25M

104.20%

-2.27M

2024Q3

2125

380.57M

105.64%

-16.02M

2024Q2

2097

395.55M

99.88%

+7.96M

2024Q1

2075

388.09M

102.93%

-19.55M

2023Q4

2061

396.17M

102.99%

+6.26M

2023Q3

1969

388.25M

103.58%

-414.67K

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

49.27M

12.63%

+1.13M

+2.34%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

24.32M

6.24%

+77.71K

+0.32%

Sep 30, 2025

State Street Investment Management (US)

16.86M

4.32%

-2.96K

-0.02%

Sep 30, 2025

Baillie Gifford & Co.

15.88M

4.07%

-823.03K

-4.93%

Sep 30, 2025

Geode Capital Management, L.L.C.

10.96M

2.81%

+197.42K

+1.83%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

8.75M

2.24%

+531.05K

+6.46%

Dec 31, 2025

Citadel Advisors LLC

6.78M

1.74%

+5.41M

+395.24%

Sep 30, 2025

Nuveen LLC

6.15M

1.58%

-1.15M

-15.70%

Sep 30, 2025

Jennison Associates LLC

10.09M

2.59%

-1.43M

-12.39%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

5.19M

1.33%

+237.59K

+4.79%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Tue, Dec 2

Name

Anteil

Global X Internet of Things ETF

3.86%

iShares U.S. Medical Devices ETF

2.71%

Motley Fool Global Opportunities ETF

1.9%

First Trust Growth Strength ETF

1.74%

Putnam Sustainable Future ETF

1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

1.51%

Invesco S&P 500 Equal Weight Health Care ETF

1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

0.83%

iShares Russell Mid-Cap Growth ETF

0.7%

Global X Internet of Things ETF

Anteil3.86%

iShares U.S. Medical Devices ETF

Anteil2.71%

Motley Fool Global Opportunities ETF

Anteil1.9%

First Trust Growth Strength ETF

Anteil1.74%

Putnam Sustainable Future ETF

Anteil1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

Anteil1.51%

Invesco S&P 500 Equal Weight Health Care ETF

Anteil1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

Anteil0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

Anteil0.83%

iShares Russell Mid-Cap Growth ETF

Anteil0.7%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Mar 28, 2022

Split

1→4

Datum

Ex-Dividendentag

Art

Verhältnis

Mar 28, 2022

Split

1→4